Nomura Holdings’s Axsome Therapeutics AXSM Stock Holding History

Nomura Holdings’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$1.83M	–	1709
2025 Q4	$1.83M	Hold	10,000	–	–	﹤0.01%	1128
2025 Q3	$1.21M	Buy	+10,000	New	+$1.13M	﹤0.01%	1331
2025 Q2	–	Sell	-17,500	Closed	-$2.04M	–	1463
2025 Q1	$2.04M	Buy	17,500 +15,000	+600%	+$1.71M	﹤0.01%	1051
2024 Q4	$212K	Sell	2,500 -2,500	-50%	-$230K	﹤0.01%	2040
2024 Q3	$449K	Buy	+5,000	New	+$436K	﹤0.01%	1271

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's AXSM Position: Q1 2026 in Review

Nomura Holdings opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 24,637 shares worth $4.16M. The stake represents 0.01% of the portfolio and ranks #696 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in AXSM as recently as Q4 2024.

Nomura Holdings first reported a position in AXSM in Q2 2024 and has held it in 4 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Nomura Holdings held 24,637 shares of Axsome Therapeutics worth $4.16M as of Q1 2026.
Axsome Therapeutics was a new Nomura Holdings position in Q1 2026.
Axsome Therapeutics made up 0.01% of Nomura Holdings's portfolio in Q1 2026, its #696 holding.
Nomura Holdings first reported a position in Axsome Therapeutics in Q2 2024 and has held it in 4 quarters since.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.